• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腕管综合征患者中心脏淀粉样变性的患病率。

Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome.

机构信息

Department of Cardiology, Hospital Universitario Puerta de Hierro, Manuel de Falla, 2. Majadahonda, 28222, Madrid, Spain.

Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro, Madrid, Spain.

出版信息

J Cardiovasc Transl Res. 2019 Dec;12(6):507-513. doi: 10.1007/s12265-019-09895-0. Epub 2019 Jun 18.

DOI:10.1007/s12265-019-09895-0
PMID:31214980
Abstract

Carpal tunnel syndrome (CTS) is a common finding among patients with cardiac amyloidosis. We sought to determine the prevalence of cardiac amyloidosis in patients who had undergone CTS surgery. From 2005 to 2014, 308 patients ≥ 60 years underwent CTS surgery. Of these, 233 (76%) agreed to participate in the study and 101 (73 ± 8 years; 68% females) showed left ventricular hypertrophy (LVH) ≥ 12 mm and underwent additional studies to diagnose AL and ATTR amyloidosis. Based on complementary studies, three patients were diagnosed with cardiac amyloidosis (two wild-type ATTR and one AL). The three patients showed bilateral CTS with no occupational risk factors. Prevalence of cardiac amyloidosis in the overall cohort was only 1.2% (3/233), but among patients with LVH and bilateral CTS, the prevalence was 5.5% (3/55) and 13.6% (3/22) if cases with an occupational risk factor were excluded. Cardiac amyloidosis should be excluded in the presence of bilateral CTS and particularly if an occupational risk factor is absent.

摘要

腕管综合征(CTS)是心脏淀粉样变性患者的常见表现。我们旨在确定行 CTS 手术患者中心脏淀粉样变性的患病率。2005 年至 2014 年间,308 名年龄≥60 岁的患者接受了 CTS 手术。其中,233 名(76%)同意参与研究,101 名(73±8 岁;68%为女性)出现左心室肥厚(LVH)≥12mm,并进行了其他研究以诊断 AL 和ATTR 淀粉样变性。根据补充研究,三名患者被诊断为心脏淀粉样变性(两例野生型ATTR 和一例 AL)。这三名患者均表现为双侧 CTS,且无职业性危险因素。在整个队列中,心脏淀粉样变性的患病率仅为 1.2%(3/233),但在出现 LVH 和双侧 CTS 的患者中,如果排除有职业性危险因素的病例,患病率分别为 5.5%(3/55)和 13.6%(3/22)。如果存在双侧 CTS,特别是在无职业性危险因素的情况下,应排除心脏淀粉样变性。

相似文献

1
Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome.腕管综合征患者中心脏淀粉样变性的患病率。
J Cardiovasc Transl Res. 2019 Dec;12(6):507-513. doi: 10.1007/s12265-019-09895-0. Epub 2019 Jun 18.
2
Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?腕管综合征和椎管狭窄:转甲状腺素蛋白淀粉样心肌病的先兆?
Clin Res Cardiol. 2019 Dec;108(12):1324-1330. doi: 10.1007/s00392-019-01467-1. Epub 2019 Apr 5.
3
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.心脏淀粉样变性中的腕管综合征:对不同病因谱的早期诊断和预后作用的影响。
Eur J Heart Fail. 2020 Mar;22(3):507-515. doi: 10.1002/ejhf.1742. Epub 2020 Jan 23.
4
Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS).在腕管综合征手术(CACTuS)患者中鉴定野生型转甲状腺素蛋白心脏淀粉样变性。
ESC Heart Fail. 2023 Feb;10(1):234-244. doi: 10.1002/ehf2.14173. Epub 2022 Oct 3.
5
Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition.腕管松解术中伴有淀粉样蛋白沉积患者的心脏淀粉样变性患病率。
Circ J. 2023 Jul 25;87(8):1047-1055. doi: 10.1253/circj.CJ-23-0223. Epub 2023 Jun 13.
6
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study.接受双侧腕管手术的男性患者中转甲状腺素蛋白淀粉样心肌病的患病率:ACTUAL 研究。
Int J Cardiol. 2021 Apr 15;329:144-147. doi: 10.1016/j.ijcard.2020.12.044. Epub 2020 Dec 30.
7
Hand surgeons and amyloidosis specialists warning: transthyretin-associated amyloidosis with bifid median nerve as a cause of bilateral carpal tunnel syndrome. A case report and literature review.手外科医生和淀粉样变性病专家警告:以正中神经分支为病因的转甲状腺素蛋白相关性淀粉样变性病导致双侧腕管综合征。病例报告及文献综述。
Eur J Orthop Surg Traumatol. 2022 Apr;32(3):575-581. doi: 10.1007/s00590-021-03004-1. Epub 2021 May 29.
8
Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.腕管松解术患者的腱鞘炎和心脏淀粉样变性。
J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.
9
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype.肌腱膜并发症可在肥厚型心肌病表型患者中识别转甲状腺素蛋白心脏淀粉样变。
J Intern Med. 2021 Jun;289(6):831-839. doi: 10.1111/joim.13200. Epub 2020 Dec 8.
10
Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.腕管综合征:系统性野生型转甲状腺素蛋白淀粉样变性(ATTRwt)的常见初始症状。
Amyloid. 2016;23(1):58-63. doi: 10.3109/13506129.2015.1135792. Epub 2016 Feb 8.

引用本文的文献

1
Value of Early Diagnosis and Treatment of Amyloidosis: A Pilot Study of Synovial Biopsy During Carpal Tunnel Release.淀粉样变性早期诊断与治疗的价值:腕管松解术中滑膜活检的初步研究
J Hand Surg Glob Online. 2025 Jul 23;7(5):100779. doi: 10.1016/j.jhsg.2025.100779. eCollection 2025 Sep.
2
Carpal Tunnel Syndrome as a Potential Indicator of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis.腕管综合征作为心脏淀粉样变性的潜在指标:一项系统评价和荟萃分析
Cureus. 2024 Dec 12;16(12):e75582. doi: 10.7759/cureus.75582. eCollection 2024 Dec.
3
Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach.

本文引用的文献

1
Cardiac amyloidosis: An update on diagnosis and treatment.心脏淀粉样变性:诊断与治疗的最新进展。
Cleve Clin J Med. 2017 Dec;84(12 Suppl 3):12-26. doi: 10.3949/ccjm.84.s3.02.
2
Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis.肱二头肌远端肌腱断裂与野生型转甲状腺素蛋白心脏淀粉样变性之间的关联。
JAMA. 2017 Sep 12;318(10):962-963. doi: 10.1001/jama.2017.9236.
3
Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.转甲状腺素蛋白心脏淀粉样变的诊断与治疗。进展与希望。
诊断轻链型和转甲状腺素蛋白淀粉样变心肌病:多学科方法
J Clin Med. 2024 Oct 1;13(19):5873. doi: 10.3390/jcm13195873.
4
Epidemiological Changes in Transthyretin Cardiac Amyloidosis: Evidence from In Vivo Data and Autoptic Series.转甲状腺素蛋白心脏淀粉样变性的流行病学变化:来自体内数据和尸检系列的证据。
J Clin Med. 2024 Aug 29;13(17):5140. doi: 10.3390/jcm13175140.
5
Early Diagnosis of Amyloidosis and Cardiac Involvement through Carpal Tunnel Surgery and Predictive Factors.通过腕管手术实现淀粉样变性和心脏受累的早期诊断及预测因素
J Clin Med. 2024 Jul 24;13(15):4328. doi: 10.3390/jcm13154328.
6
Carpal tunnel syndrome.腕管综合征。
Nat Rev Dis Primers. 2024 May 23;10(1):37. doi: 10.1038/s41572-024-00521-1.
7
Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure.所有非缺血性心力衰竭患者人群的死亡率的病因和预测因素。
Clin Res Cardiol. 2024 May;113(5):737-749. doi: 10.1007/s00392-023-02354-6. Epub 2024 Jan 15.
8
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).世界心脏联合会关于转甲状腺素蛋白淀粉样变性心肌病(ATTR-CM)的共识。
Glob Heart. 2023 Oct 26;18(1):59. doi: 10.5334/gh.1262. eCollection 2023.
9
Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review.与转甲状腺素蛋白介导的(ATTR)淀粉样变性相关的肌肉骨骼表现:系统评价。
BMC Musculoskelet Disord. 2023 Sep 22;24(1):751. doi: 10.1186/s12891-023-06853-5.
10
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.台湾心脏病学会2023年心脏淀粉样变诊断与治疗专家共识
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):991-1004. doi: 10.1016/j.rec.2017.05.036. Epub 2017 Sep 1.
4
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.解答心脏淀粉样变性诊断与管理中遇到的常见问题。
Circulation. 2017 Apr 4;135(14):1357-1377. doi: 10.1161/CIRCULATIONAHA.116.024438.
5
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.野生型转甲状腺素蛋白心脏淀粉样变的临床特征:破除迷思。
Eur Heart J. 2017 Jun 21;38(24):1895-1904. doi: 10.1093/eurheartj/ehx043.
6
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.非活检诊断心脏转甲状腺素淀粉样变性。
Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22.
7
Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.腕管综合征:系统性野生型转甲状腺素蛋白淀粉样变性(ATTRwt)的常见初始症状。
Amyloid. 2016;23(1):58-63. doi: 10.3109/13506129.2015.1135792. Epub 2016 Feb 8.
8
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.轻链型淀粉样变性:来自淀粉样变性研究联盟的患者体验调查。
Adv Ther. 2015 Oct;32(10):920-8. doi: 10.1007/s12325-015-0250-0. Epub 2015 Oct 23.
9
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.野生型转甲状腺素蛋白淀粉样变性导致射血分数保留的心力衰竭。
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
10
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.特发性淀粉样多发性神经病用塔法米迪治疗:一项随机对照试验。
Neurology. 2012 Aug 21;79(8):785-92. doi: 10.1212/WNL.0b013e3182661eb1. Epub 2012 Jul 25.